Navigation Links
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex
Date:5/13/2010

The joint venture Abbymex is announced by Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. to provide a consistent supply of logwood extract used in the production of hematoxylin and hematine. Hematoxylin is a key ingredient in stains used by biological laboratories for Pap smear tests and hematine is used to dye medical sutures. Abbey Color is the world’s largest manufacturer of both hematoxylin and hematine.

Philadelphia, PA (PRWEB) May 13, 2010 -- Abbey Color Inc., located in Philadelphia, Pennsylvania, USA, announces a joint venture with Mexicana de Extractos International, S.A. de C.V., located in Campeche, Mexico. Mexicana de Extractos has supplied logwood extract to Abbey Color Inc. for their Hematoxylin and Hematine production for over thirty years and the newly formed joint venture, registered as Abbymex, is being built on the strong foundation of mutual respect and trust that has evolved over the years because of the high principles espoused by both companies.

“We are very excited about this venture,” explained Roger Nielsen, President and Owner of Abbey Color Inc. “This investment continues our strategic plan to meet the critical need for Hematoxylin and Hematine in the health industry worldwide. This is a responsibility we take very seriously, and we have demonstrated our commitment through our substantial investment in this joint venture. We are pleased to partner with Mexicana de Extractos, a company of excellent reputation and one which shares our values and our vision. As a result of this venture, our customers throughout the world can purchase their materials, confident in the knowledge that problems with periodic shortages will now be a thing of the past. In accordance with the integrity principles of our combined companies, we have also resolved to maintain a consistent and reasonable pricing structure, as we have done in the past.”

This venture signifies both parties’ dedication to continue supplying hematoxylin to the Hemotoxylin and Eosin Y (H&E) stain markets in North America and throughout the world. Agreements within the formulation of the Abbymex joint venture will ensure continuous and consistent supply of logwood extract to the Abbey Color facility in Philadelphia as to maintain uninterrupted production and inventory building of hematoxylin and hematine.

About Abbey Color Inc.
Abbey Color is a premier dye manufacturer and supplier of industrial dyes, dye precursors and colorants serving various domestic and international markets ranging from healing practices to industrial uses. Abbey Color is the world’s leading manufacturer of hematoxylin and is the only dye manufacturer in the world that makes both hematoxylin and eosin Y. Abbey Color is a supplier to the makers of various biological stain products and hematoxylin is always in stock. Abbey Color's hematoxylin is certified by the Biological Stain Commission (BSC). Hematoxylin is the key ingredient in stains used by biological laboratories and pathologists for Pap smear tests using H&E stain and other procedures. Hematine is used for the dyeing of silk that is used in medical sutures. Abbey Color is a ChemStewards® certified facility.

Contact Abbey Color
For more information or to inquire about Abbey Color’s products and services, including hematoxylin, hematine, logwood extract and biological stain products, please call 215-739-9960 or visit the Abbey Color website at www.AbbeyColor.com.

###

Read the full story at http://www.prweb.com/releases/abbymex/joint-venture/prweb3995624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Exploring gender differences in colorectal cancer screenings
2. Homewatch CareGivers Show in Colorado is Next for SilverStone Group's In-Home Care Team
3. Plastics Color Corporation Expands Into California
4. Three Genes Linked to Variations in Eye Color
5. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
6. Investigators examine colorectal cancer screening methods among diverse populations
7. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
8. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
9. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
10. Hispanics live in areas with limited capacity for colorectal cancer screening
11. Leukemia-related protein 16 and colorectal carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex 
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
Breaking Medicine Technology: